Jefferies Maintains a 'Buy' on Infinity Pharmaceutical (INFI); Wider Loss, But Sufficient Cash Through 1H13

Go back to Jefferies Maintains a 'Buy' on Infinity Pharmaceutical (INFI); Wider Loss, But Sufficient Cash Through 1H13
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) Delayed: 0.04 --0 (-0%)
Previous Close $0.04    52 Week High $8.98 
Open $11.23    52 Week Low $0.84 
Day High $0.04    P/E N/A 
Day Low $0.04    EPS $-3.42 
Volume 87,833